1. Home
  2. ONC vs ZBH Comparison

ONC vs ZBH Comparison

Compare ONC & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • ZBH
  • Stock Information
  • Founded
  • ONC 2010
  • ZBH 1927
  • Country
  • ONC Cayman Islands
  • ZBH United States
  • Employees
  • ONC N/A
  • ZBH N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • ZBH Industrial Specialties
  • Sector
  • ONC Health Care
  • ZBH Health Care
  • Exchange
  • ONC Nasdaq
  • ZBH Nasdaq
  • Market Cap
  • ONC 19.3B
  • ZBH 21.8B
  • IPO Year
  • ONC N/A
  • ZBH N/A
  • Fundamental
  • Price
  • ONC $255.37
  • ZBH $104.83
  • Analyst Decision
  • ONC
  • ZBH Hold
  • Analyst Count
  • ONC 0
  • ZBH 23
  • Target Price
  • ONC N/A
  • ZBH $124.43
  • AVG Volume (30 Days)
  • ONC 357.2K
  • ZBH 1.9M
  • Earning Date
  • ONC 02-27-2025
  • ZBH 02-06-2025
  • Dividend Yield
  • ONC N/A
  • ZBH 0.92%
  • EPS Growth
  • ONC N/A
  • ZBH N/A
  • EPS
  • ONC N/A
  • ZBH 4.43
  • Revenue
  • ONC $3,351,304,621.00
  • ZBH $7,678,600,000.00
  • Revenue This Year
  • ONC $992.37
  • ZBH $5.36
  • Revenue Next Year
  • ONC $24.68
  • ZBH $4.57
  • P/E Ratio
  • ONC N/A
  • ZBH $23.39
  • Revenue Growth
  • ONC 50.22
  • ZBH 3.85
  • 52 Week Low
  • ONC $126.97
  • ZBH $97.69
  • 52 Week High
  • ONC $260.98
  • ZBH $133.90
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • ZBH 48.37
  • Support Level
  • ONC N/A
  • ZBH $99.43
  • Resistance Level
  • ONC N/A
  • ZBH $108.88
  • Average True Range (ATR)
  • ONC 0.00
  • ZBH 2.23
  • MACD
  • ONC 0.00
  • ZBH 0.02
  • Stochastic Oscillator
  • ONC 0.00
  • ZBH 58.67

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Share on Social Networks: